159 related articles for article (PubMed ID: 15978195)
1. Chitosan-DNA microparticles as mucosal delivery system: synthesis, characterization and release in vitro.
Li YH; Fan MW; Bian Z; Chen Z; Zhang Q; Yang HR
Chin Med J (Engl); 2005 Jun; 118(11):936-41. PubMed ID: 15978195
[TBL] [Abstract][Full Text] [Related]
2. [Feasibility of chitosan as gene therapy vehicle].
Wan YY; Zhang X; He YJ; Jiang WQ
Ai Zheng; 2005 Nov; 24(11):1408-11. PubMed ID: 16552973
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA:poly(L-lysine) complexes.
Aral C; Akbuga J
J Pharm Pharm Sci; 2003; 6(3):321-6. PubMed ID: 14738712
[TBL] [Abstract][Full Text] [Related]
4. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
5. Chitosan microparticles containing plasmid DNA as potential oral gene delivery system.
Guliyeva U; Oner F; Ozsoy S; Haziroğlu R
Eur J Pharm Biopharm; 2006 Jan; 62(1):17-25. PubMed ID: 16257520
[TBL] [Abstract][Full Text] [Related]
6. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
Huang YC; Chiang CH; Yeh MK
J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
Wittaya-areekul S; Kruenate J; Prahsarn C
Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
[TBL] [Abstract][Full Text] [Related]
8. Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats.
Liu GX; Xu QA; Jin J; Li YH; Jia R; Guo JH; Fan MW
Vaccine; 2009 May; 27(22):2940-7. PubMed ID: 19428904
[TBL] [Abstract][Full Text] [Related]
9. Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle.
Ozbas-Turan S; Aral C; Kabasakal L; Keyer-Uysal M; Akbuga J
J Pharm Pharm Sci; 2003; 6(1):27-32. PubMed ID: 12753728
[TBL] [Abstract][Full Text] [Related]
10. Chitosan based delivery systems for mucosal immunization against bovine herpesvirus 1 (BHV-1).
Günbeyaz M; Faraji A; Ozkul A; Puralı N; Senel S
Eur J Pharm Sci; 2010 Nov; 41(3-4):531-45. PubMed ID: 20800678
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation of adenoviral vectors into chitosan-bile salt microparticles for mucosal vaccination.
Lameiro MH; Malpique R; Silva AC; Alves PM; Melo E
J Biotechnol; 2006 Nov; 126(2):152-62. PubMed ID: 16757053
[TBL] [Abstract][Full Text] [Related]
12. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination.
Borges O; Cordeiro-da-Silva A; Romeijn SG; Amidi M; de Sousa A; Borchard G; Junginger HE
J Control Release; 2006 Sep; 114(3):348-58. PubMed ID: 16905219
[TBL] [Abstract][Full Text] [Related]
13. Plasmid-DNA loaded chitosan microspheres for in vitro IL-2 expression.
Akbuğa J; Ozbaş-Turan S; Erdoğan N
Eur J Pharm Biopharm; 2004 Nov; 58(3):501-7. PubMed ID: 15451524
[TBL] [Abstract][Full Text] [Related]
14. TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines.
Sayin B; Somavarapu S; Li XW; Sesardic D; Senel S; Alpar OH
Eur J Pharm Sci; 2009 Nov; 38(4):362-9. PubMed ID: 19733658
[TBL] [Abstract][Full Text] [Related]
15. Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa.
Simonoska Crcarevska M; Glavas Dodov M; Goracinova K
Eur J Pharm Biopharm; 2008 Mar; 68(3):565-78. PubMed ID: 17651952
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells.
Weecharangsan W; Opanasopit P; Ngawhirunpat T; Apirakaramwong A; Rojanarata T; Ruktanonchai U; Lee RJ
Int J Pharm; 2008 Feb; 348(1-2):161-8. PubMed ID: 17714894
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of a model protein into chitosan-bile salt microparticles.
Lameiro MH; Lopes A; Martins LO; Alves PM; Melo E
Int J Pharm; 2006 Apr; 312(1-2):119-30. PubMed ID: 16480840
[TBL] [Abstract][Full Text] [Related]
18. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice.
Jiang L; Qian F; He X; Wang F; Ren D; He Y; Li K; Sun S; Yin C
J Gene Med; 2007 Apr; 9(4):253-64. PubMed ID: 17397104
[TBL] [Abstract][Full Text] [Related]
19. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP
Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization and delivery of chitosan-DNA microparticles into mammalian cells.
Dastan T; Turan K
J Pharm Pharm Sci; 2004 Jun; 7(2):205-14. PubMed ID: 15367377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]